Loading...
•
Jun 30, 2021
Globus Medical Q2 2021 Earnings Report
Globus Medical's Q2 2021 results were announced, demonstrating substantial revenue growth and increased profitability compared to the previous year.
Key Takeaways
Globus Medical reported record revenue of $251 million for Q2 2021, a 69% increase year-over-year. The company's U.S. Spine business grew significantly, and Enabling Technologies revenue nearly quadrupled. GAAP net income and EPS also saw substantial increases.
Worldwide net sales reached $251.0 million, a 68.6% increase compared to Q2 2020.
GAAP net income for the quarter was $41.5 million, representing 16.6% of net sales, a 299.4% increase year-over-year.
GAAP diluted earnings per share (EPS) was $0.40, and non-GAAP diluted EPS was $0.56.
Non-GAAP adjusted EBITDA was $87.8 million, or 35.0% of net sales.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The company increased guidance for full year 2021 net sales from $925 million to $950 million and non-GAAP diluted earnings per share of $1.89 to $2.00.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...